Hit enter to search or ESC to close
Catholic Employer Health Alliance
  • About CEHA
    • Our Purpose
    • Leadership
    • Summary of Current Plans
  • Prospective Members
    • Summary of Current Plans
    • Request Information
    • Frequently Asked Questions: For Prospective Employers
  • Employees & Families
    • Benefits & Resources
    • Frequently Asked Questions
  • Success Stories
  • HR Administrators
  • About CEHA
    • Our Purpose
    • Leadership
    • Summary of Current Plans
  • Prospective Members
    • Summary of Current Plans
    • Request Information
    • Frequently Asked Questions: For Prospective Employers
  • Employees & Families
    • Benefits & Resources
    • Frequently Asked Questions
  • Success Stories
  • HR Administrators

In Caremark’s ongoing effort to assist our Plan in maximizing our health care investment while offering your plan members clinically appropriate prescription therapy, Caremark announced changes to the Standard Formulary effective October 1st, 2020. A copy of the Performance Drug List can be found here.  ***Please note, although Contraceptives are listed on the formulary, our plan does not cover these drugs.*** 

The formulary review process focused on many factors, including:

  1. Adding products that have demonstrated enhanced clinical efficacy and/or provide more convenient dosage forms, AND/OR
  2. Removing products that may have less convenient dosage forms, may have more side effects or may cost more when compared to available options on the CVS Caremark® Drug List.  The 10/1/2020 Formulary Drug Removals List can be found here.


Member Notification Process:

As always, notifications are sent to members via USPS who are affected by tier changes or drug exclusions. Please encourage your members to use the CVS Caremark website, Caremark.com, to view the most current version of the drug list, as well as to review their prescription drug benefit information, request mail service orders and research drug information.

We appreciate the opportunity to serve you and your members’ prescription benefit needs. If you have any questions regarding these changes, please do not hesitate to contact the Trust!

– CEHA Participant about

As a follow-up to the June 10th update regarding the Formulary update that takes effect today, Caremark provided the additional detailed information below.

In Caremark’s ongoing effort to assist our Plan in maximizing our health care investment while offering your plan members clinically appropriate prescription therapy, Caremark announced changes to the Standard Formulary effective July 1st, 2020. A copy of the Performance Drug List can be found here.  ***Please note, although Contraceptives are listed on the formulary, our plan does not cover these drugs.*** 

The formulary review process focused on many factors, including:

1.Adding products that have demonstrated enhanced clinical efficacy and/or provide more convenient dosage forms.  Tier 2 (Preferred):

  • BAQSIMI NASAL POWDER
  • EMGALITY PFS
  • NURTEC ORALLY DISINTEGRATING TABLET (ODT)
  • PRALUENT PEN/INJECTION
  • RYBELSUS TABLET
  • SYMJEPI INJECTION
  • TAKHZYRO VIAL
  • VUMERITY CAPSULE
  • BRYHALI LOTION
  • LO LOESTRIN FE TABLET
  • ONEXTON GEL
  • REYVOW TABLET
  • STELARA VIAL
  • SYMTUZA TABLET
  • UBRELVY TABLET
  • YUPELRI SOLUTION

 

2.Removing products that may have less convenient dosage forms, may have more side effects or may cost more when compared to available options on the CVS Caremark® Drug List.  Please note some of the exclusions have been previously communicated.

 a. Formulary Exclusions:

  • BELVIQ TABLET
  • BELVIQ XR TABLET
  • BIMATOPROST OPHTHALMIC SOLUTION
  • BUPROPION 450MG XL TABLET
  • CHLORZOXAZONE 375MG TABLET
  • CHLORZOXAZONE 750MG TABLET
  • CLINDAMYCIN GEL
  • COREMINO TABLET
  • CYCLOBENZAPRINE ER CAPSULE
  • DOXYCYCLINE HYCLATE 150MG TABLET
  • DOXYCYCLINE HYCLATE 200MG DR TABLET
  • DOXYCYCLINE HYCLATE 50MG TABLET
  • DOXYCYCLINE HYCLATE 75MG TABLET
  • DOXYCYCLINE MONOHYDRATE 150MG CAPSULE
  • DOXYCYCLINE MONOHYDRATE 75MG CAPSULE
  • ERGOTAMINE-CAFFEINE TABLET
  • FLUCYTOSINE 500MG CAPSULE
  • FLUOXETINE 60MG TABLET
  • FLURANDRENOL LOTION
  • HYDROCORTISONE BUTYRATE CREAM
  • HYDROCORTISONE BUTYRATE LIPID CREAM
  • KETOPROFEN 25MG CAPSULE
  • LORZONE TABLET
  • MINOCYCLINE ER TABLET
  • MONDOXYNE NL 75MG CAPSULE
  • OKEBO 75MG CAPSULE
  • ORPHENADRINE CITRATE-ASPIRIN-CAFFEINE TABLET
  • ORPHENGESIC FORTE TABLET
  • POSACONAZOLE DR TABLET
  • REPATHA PUSHTRONEX SYSTEM
  • REPATHA SURECLICK PEN
  • REPATHA SYRINGE
  • SUMATRIPTAN-NAPROXEN TABLET
  • TREXIMET TABLET
  • TRIAMCINOLONE TOPICAL SPRAY

b. Tier 2 to Tier 3:

  • APRISO CAPSULE
  • ESGIC APAP TABLET
  • MIRCETTE TABLET
  • NUVARING VAGINAL RING
  • ULORIC TABLET
  • ZANAFLEX TABLET
  • DAYPRO TABLET
  • ISORDIL TITRADOSE TABLET
  • MOBIC TABLET
  • SENSIPAR TABLET
  • ULTRAM TABLET


Mailing Process:

As always, notifications are sent to members who are negatively affected by tier changes or drug exclusions. Please encourage your members to use the CVS Caremark website, Caremark.com, to view the most current version of the drug list, as well as to review their prescription drug benefit information, request mail service orders and research drug information.

 

We appreciate the opportunity to serve you and your members’ prescription benefit needs. If you have any questions regarding these changes, please do not hesitate to contact the Trust!

– CEHA Participant about

– CEHA Participant about

– CEHA Participant about

– CEHA Participant about

Prescription Drug

1.800.334.8134 member.rxbenefits.com

Carrier
CVS Caremark

Telehealth

888.632.2738 http://www.mdlive.com/ect

Carrier
MD Live

Medical Disease & Case Management

1.800.459.2110 x 2247 http://www.coniferhealth.com

Carrier
Conifer Health Solutions

– CEHA Participant about

Previous 1 2

About the Trust

History

Leadership

Summary of Current Plans

Prospective Members

Summary of Current Plans

Request Information

Enrolled Employees & Families

Benefits & Resources

FAQs

Success Stories

HR Administrators

To provide you with a better experience, this website uses cookies. By continuing to browse our site, you are agreeing to our use of cookies. Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT